The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group study.
Eur J Obstet Gynecol Reprod Biol
; 243: 120-124, 2019 Dec.
Article
em En
| MEDLINE
| ID: mdl-31689674
ABSTRACT
OBJECTIVE:
To compare survival measures of women with early-stage endometrial cancer who underwent either hysteroscopy or a non-hysteroscopic procedure as a diagnostic procedure. STUDYDESIGN:
An Israel Gynecologic Oncology Group multicenter study of 1324 patients with stage I endometrial cancer who underwent surgery between 2002 and 2014. Patients were divided into two groups hysteroscopy and non-hysteroscopy (curettage or office endometrial biopsy). Clinical, pathological, and survival measures were compared between the groups.RESULTS:
There were 355 patients in the hysteroscopy group and 969 patients in the non-hysteroscopy group. The median follow-up was 52 months (range 12-120 months). There were no differences between the groups in the 5-year recurrence-free survival (90.2% vs. 88.2%; pâ¯=â¯0.53), disease-specific survival (93.4% vs. 91.7%; pâ¯=â¯0.5), and overall survival (86.2% vs. 80.6%; pâ¯=â¯0.22).CONCLUSION:
Our findings affirm that hysteroscopy does not compromise the survival of patients with early-stage endometrial cancer.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Carcinossarcoma
/
Histeroscopia
/
Neoplasias do Endométrio
/
Carcinoma Endometrioide
/
Adenocarcinoma de Células Claras
Tipo de estudo:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
/
Middle aged
País/Região como assunto:
Asia
Idioma:
En
Revista:
Eur J Obstet Gynecol Reprod Biol
Ano de publicação:
2019
Tipo de documento:
Article